TY - JOUR
T1 - Solid implantable devices for sustained drug delivery
AU - Magill, Elizabeth
AU - Demartis, Sara
AU - Gavini, Elisabetta
AU - Permana, Andi Dian
AU - Thakur, Raghu Raj Singh
AU - Adrianto, Muhammad Faris
AU - Waite, David
AU - Glover, Katie
AU - Picco, Camila J.
AU - Korelidou, Anna
AU - Detamornrat, Usanee
AU - Vora, Lalitkumar K.
AU - Li, Linlin
AU - Anjani, Qonita Kurnia
AU - Donnelly, Ryan F.
AU - Domínguez-Robles, Juan
AU - Larrañeta, Eneko
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/8
Y1 - 2023/8
N2 - Implantable drug delivery systems (IDDS) are an attractive alternative to conventional drug administration routes. Oral and injectable drug administration are the most common routes for drug delivery providing peaks of drug concentrations in blood after administration followed by concentration decay after a few hours. Therefore, constant drug administration is required to keep drug levels within the therapeutic window of the drug. Moreover, oral drug delivery presents alternative challenges due to drug degradation within the gastrointestinal tract or first pass metabolism. IDDS can be used to provide sustained drug delivery for prolonged periods of time. The use of this type of systems is especially interesting for the treatment of chronic conditions where patient adherence to conventional treatments can be challenging. These systems are normally used for systemic drug delivery. However, IDDS can be used for localised administration to maximise the amount of drug delivered within the active site while reducing systemic exposure. This review will cover current applications of IDDS focusing on the materials used to prepare this type of systems and the main therapeutic areas of application.
AB - Implantable drug delivery systems (IDDS) are an attractive alternative to conventional drug administration routes. Oral and injectable drug administration are the most common routes for drug delivery providing peaks of drug concentrations in blood after administration followed by concentration decay after a few hours. Therefore, constant drug administration is required to keep drug levels within the therapeutic window of the drug. Moreover, oral drug delivery presents alternative challenges due to drug degradation within the gastrointestinal tract or first pass metabolism. IDDS can be used to provide sustained drug delivery for prolonged periods of time. The use of this type of systems is especially interesting for the treatment of chronic conditions where patient adherence to conventional treatments can be challenging. These systems are normally used for systemic drug delivery. However, IDDS can be used for localised administration to maximise the amount of drug delivered within the active site while reducing systemic exposure. This review will cover current applications of IDDS focusing on the materials used to prepare this type of systems and the main therapeutic areas of application.
KW - Biodegradable polymers
KW - Implant
KW - Local drug delivery
KW - Sustained drug release
UR - http://www.scopus.com/inward/record.url?scp=85161812883&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2023.114950
DO - 10.1016/j.addr.2023.114950
M3 - Review article
C2 - 37295560
AN - SCOPUS:85161812883
SN - 0169-409X
VL - 199
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
M1 - 114950
ER -